IL17A and breast cancer: Using bioinformatics tools, they also discovered that both CD and BC were associated with the IL-17 and NF-κB signaling pathways.[21] Another prospective study noted an increase in the standardized incidence of BC in both UC and CD populations.[22] BC resistance protein is an efflux transporter that protects intestinal cells from toxic compounds.